Activist investment firm Starboard Value has launched a proxy battle with pharmacy supplier Kenvue, running a slate of four board nominees including Starboard head Jeff Smith. Kenvue, a maker of ...

As Starboard has recommended, spinning off or selling the Life Sciences business is a simple solution to a simple problem. The short-term value creation here is straightforward. If separated ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people familiar with the matter. Starboard did not nominate any directors ...

Activist Commentary: Starboard is a very successful activist investor and has extensive experience helping companies focus on operational efficiency and margin improvement. Starboard has initiated ...

Following a tough opening salvo from Starboard Value last fall, Pfizer is getting a chance to catch its breath in the activist investor’s unfolding proxy fight. Starboard stopped short of ...